Compare DexCom, Inc. (DXCM) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Marathon Digital Holdings Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Marathon Digital Holdings Inc trades at $9.65 (market cap $3.83B). The key difference: DexCom, Inc. is far larger — about 8.3× Marathon Digital Holdings Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Marathon Digital Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Marathon Digital Holdings Inc for 22 Days on average.
| DXCM | MARA | |
|---|---|---|
Market Cap | $31.86B | $3.83B |
Volume | 3,607,070 | 47,742,698 |
Sector | Health | Financials |
52-Week High | $92.34 | $22.84 |
52-Week Low | $54.84 | $6.73 |
Typical Hold Time | 62 Days | 22 Days |
Enterprise Value | $31.32B | $5.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
MARA trades at $9.91, down 4.34% today, with a bearish technical outlook despite some oversold RSI readings. The company faces severe profitability challenges with a net income margin of -429.71% and negative cash flow from operations of $802.73M in 2025. Recent earnings misses and declining revenue from $907M in 2025 to $804M in 2026 highlight operational struggles, though analyst consensus remains divided with a $13 price target.
The stock presents high risk due to persistent losses and negative cash generation, offset by potential upside if operational efficiency improves. Investors face volatility from Bitcoin sector exposure and regulatory uncertainty, requiring careful risk assessment despite Wall Street's mixed but leaning positive ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
